CompletedNot Applicable

MobiChina - A Prospective Multicenter Cohort Study

China284 participantsStarted 2015-04

Plain-language summary

The study will assess the difference in functionality between early vs. standard mobilization after hip fracture in the Chinese population.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 65 and older * Diagnosis of an unstable intertrochanteric fractures (AO 31- A2 or A3) treated with an intramedullary nail * Ability to walk independently or with a walking aid prior to injury * Informed consent obtained, i.e.: Ability of the patient to understand the content of the patient information / Informed Consent Form and signed and dated Institutional Review Board (IRB) / Ethics Committee (EC)-approved written informed consent Exclusion Criteria: * Severe dementia * Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment * Prisoner * Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

What they're measuring

Modified Barthel Index

Timeframe: 6 weeks postoperative

Trial details

NCT IDNCT02296086

SponsorAO Innovation Translation Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-11

View on ClinicalTrials.gov More Unstable Fracture trials